Clinical trial
Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That…
NCT00109941 · Milton S. Hershey Medical Center, Other · Completed
Key facts
| NCT number | NCT00109941 |
|---|---|
| Title | Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery |
| Official title | Treatment of Advanced Pancreatic Cancer With Opioid Growth Factor (OGF): Phase II |
| Acronym | OGF |
| Lead sponsor | Milton S. Hershey Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological |
| Interventions | opioid growth factor, metenkephalin, OGF-opioid growth factor |
| Enrollment | 25 |
| Start date | Oct 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Apr 1, 2009 |
| First posted | May 4, 2005 |
| Last update posted | Sep 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: